4577.T
Daito Pharmaceutical Co.,Ltd.
プライム · 医薬品 · 医薬品 · JP
JPY 1,314.00
−0.68%Year over year
Reported trailing growth
- Revenue
- +3.9%
- EBITDA
- —
- EBIT
- +31.7%
- EPS
- -29.7%
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- +0.5%
- EBITDA
- —
- EPS
- -14.6%
Three-year CAGR
- Revenue
- +5.2%
- EBITDA
- -11.0%
- EBIT
- -26.3%
- Net income
- -25.8%
- EPS
- -42.8%
- Free cash flow
- +7.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Feb 1, 2026